Shanghai Pioneer Holding Ltd

SEHK:1345 주식 보고서

시가총액: HK$2.7b

Shanghai Pioneer Holding 관리

관리 기준 확인 4/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Steven Yang

최고 경영자

CN¥655.0k

총 보상

CEO 급여 비율78.8%
CEO 임기1.7yrs
CEO 소유권n/a
경영진 평균 재임 기간4.5yrs
이사회 평균 재임 기간3yrs

최근 관리 업데이트

Recent updates

Shanghai Pioneer Holding Ltd (HKG:1345) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected

Dec 10
Shanghai Pioneer Holding Ltd (HKG:1345) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected

Shareholders Should Be Pleased With Shanghai Pioneer Holding Ltd's (HKG:1345) Price

Jul 15
Shareholders Should Be Pleased With Shanghai Pioneer Holding Ltd's (HKG:1345) Price

Shanghai Pioneer Holding's (HKG:1345) Dividend Will Be CN¥0.024

Apr 24
Shanghai Pioneer Holding's (HKG:1345) Dividend Will Be CN¥0.024

Shanghai Pioneer Holding (HKG:1345) Will Pay A Dividend Of CN¥0.024

Apr 03
Shanghai Pioneer Holding (HKG:1345) Will Pay A Dividend Of CN¥0.024

Shanghai Pioneer Holding's (HKG:1345) Shareholders Have More To Worry About Than Only Soft Earnings

Apr 01
Shanghai Pioneer Holding's (HKG:1345) Shareholders Have More To Worry About Than Only Soft Earnings

Shanghai Pioneer Holding Ltd (HKG:1345) Could Be Riskier Than It Looks

Mar 22
Shanghai Pioneer Holding Ltd (HKG:1345) Could Be Riskier Than It Looks

Shanghai Pioneer Holding (HKG:1345) Is Finding It Tricky To Allocate Its Capital

Feb 26
Shanghai Pioneer Holding (HKG:1345) Is Finding It Tricky To Allocate Its Capital

Does Shanghai Pioneer Holding (HKG:1345) Have A Healthy Balance Sheet?

Oct 21
Does Shanghai Pioneer Holding (HKG:1345) Have A Healthy Balance Sheet?

Shanghai Pioneer Holding (HKG:1345) Has Announced That It Will Be Increasing Its Dividend To CN¥0.024

Sep 18
Shanghai Pioneer Holding (HKG:1345) Has Announced That It Will Be Increasing Its Dividend To CN¥0.024

Shanghai Pioneer Holding (HKG:1345) Is Increasing Its Dividend To CN¥0.024

Sep 01
Shanghai Pioneer Holding (HKG:1345) Is Increasing Its Dividend To CN¥0.024

Here's Why We Think Shanghai Pioneer Holding (HKG:1345) Is Well Worth Watching

Aug 09
Here's Why We Think Shanghai Pioneer Holding (HKG:1345) Is Well Worth Watching

Shanghai Pioneer Holding's (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year

Apr 14
Shanghai Pioneer Holding's (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year

Shanghai Pioneer Holding's (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year

Mar 31
Shanghai Pioneer Holding's (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year

Shanghai Pioneer Holding (HKG:1345) Seems To Use Debt Rather Sparingly

Dec 15
Shanghai Pioneer Holding (HKG:1345) Seems To Use Debt Rather Sparingly

China Pioneer Pharma Holdings' (HKG:1345) Dividend Will Be Reduced To CN¥0.018

Sep 21
China Pioneer Pharma Holdings' (HKG:1345) Dividend Will Be Reduced To CN¥0.018

China Pioneer Pharma Holdings' (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year

Sep 02
China Pioneer Pharma Holdings' (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year

China Pioneer Pharma Holdings (HKG:1345) Has More To Do To Multiply In Value Going Forward

Jun 22
China Pioneer Pharma Holdings (HKG:1345) Has More To Do To Multiply In Value Going Forward

China Pioneer Pharma Holdings (HKG:1345) Has Announced That Its Dividend Will Be Reduced To HK$0.064

Apr 14
China Pioneer Pharma Holdings (HKG:1345) Has Announced That Its Dividend Will Be Reduced To HK$0.064

China Pioneer Pharma Holdings (HKG:1345) Will Be Hoping To Turn Its Returns On Capital Around

Jan 16
China Pioneer Pharma Holdings (HKG:1345) Will Be Hoping To Turn Its Returns On Capital Around

These 4 Measures Indicate That China Pioneer Pharma Holdings (HKG:1345) Is Using Debt Safely

Oct 11
These 4 Measures Indicate That China Pioneer Pharma Holdings (HKG:1345) Is Using Debt Safely

China Pioneer Pharma Holdings (HKG:1345) Is Paying Out Less In Dividends Than Last Year

Sep 15
China Pioneer Pharma Holdings (HKG:1345) Is Paying Out Less In Dividends Than Last Year

China Pioneer Pharma Holdings (HKG:1345) Has Announced That Its Dividend Will Be Reduced To HK$0.056

Sep 01
China Pioneer Pharma Holdings (HKG:1345) Has Announced That Its Dividend Will Be Reduced To HK$0.056

China Pioneer Pharma Holdings (HKG:1345) Will Be Looking To Turn Around Its Returns

Aug 26
China Pioneer Pharma Holdings (HKG:1345) Will Be Looking To Turn Around Its Returns

Returns On Capital At China Pioneer Pharma Holdings (HKG:1345) Paint A Concerning Picture

May 22
Returns On Capital At China Pioneer Pharma Holdings (HKG:1345) Paint A Concerning Picture

We Think China Pioneer Pharma Holdings (HKG:1345) Can Stay On Top Of Its Debt

Apr 25
We Think China Pioneer Pharma Holdings (HKG:1345) Can Stay On Top Of Its Debt

Can Mixed Financials Have A Negative Impact on China Pioneer Pharma Holdings Limited's 's (HKG:1345) Current Price Momentum?

Mar 14
Can Mixed Financials Have A Negative Impact on China Pioneer Pharma Holdings Limited's 's (HKG:1345) Current Price Momentum?

How Has China Pioneer Pharma Holdings (HKG:1345) Allocated Its Capital?

Feb 21
How Has China Pioneer Pharma Holdings (HKG:1345) Allocated Its Capital?

Should You Use China Pioneer Pharma Holdings' (HKG:1345) Statutory Earnings To Analyse It?

Feb 03
Should You Use China Pioneer Pharma Holdings' (HKG:1345) Statutory Earnings To Analyse It?

Is China Pioneer Pharma Holdings Limited (HKG:1345) At Risk Of Cutting Its Dividend?

Jan 16
Is China Pioneer Pharma Holdings Limited (HKG:1345) At Risk Of Cutting Its Dividend?

China Pioneer Pharma Holdings (HKG:1345) Has A Rock Solid Balance Sheet

Dec 29
China Pioneer Pharma Holdings (HKG:1345) Has A Rock Solid Balance Sheet

Is China Pioneer Pharma Holdings Limited's (HKG:1345) Stock Price Struggling As A Result Of Its Mixed Financials?

Dec 14
Is China Pioneer Pharma Holdings Limited's (HKG:1345) Stock Price Struggling As A Result Of Its Mixed Financials?

China Pioneer Pharma Holdings (HKG:1345) Has Gifted Shareholders With A Fantastic 124% Total Return On Their Investment

Nov 29
China Pioneer Pharma Holdings (HKG:1345) Has Gifted Shareholders With A Fantastic 124% Total Return On Their Investment

CEO 보상 분석

Steven Yang 의 보수는 Shanghai Pioneer Holding 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Jun 30 2024n/an/a

CN¥164m

Mar 31 2024n/an/a

CN¥155m

Dec 31 2023CN¥655kCN¥516k

CN¥146m

Sep 30 2023n/an/a

CN¥168m

Jun 30 2023n/an/a

CN¥190m

Mar 31 2023n/an/a

CN¥213m

Dec 31 2022CN¥752kCN¥624k

CN¥235m

보상 대 시장: Steven 의 총 보상 ($USD 89.77K ) Hong Kong 시장에서 비슷한 규모의 회사에 대한 평균보다 낮습니다( $USD 393.64K ).

보상과 수익: Steven 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.


CEO

Steven Yang (36 yo)

1.7yrs

테뉴어

CN¥655,000

보상

Mr. Yuewen Yang, also known as Steven, serves as Chief Executive Officer since April 2023 and serves as its Executive Director since September 16, 2022 and served as Chief Operating Officer at Shanghai Pio...


리더십 팀

이름위치테뉴어보상소유권
Zhang Xinzhou Li
Executive Chairman11.8yrsCN¥2.05m0.95%
HK$ 25.6m
Yuewen Yang
CEO & Executive Director1.7yrsCN¥655.00k데이터 없음
Quan Zhang
General Manager of Dental Business Division & Executive Director3.3yrsCN¥717.00k데이터 없음
Yi Xue
Chief Financial Officer8yrs데이터 없음데이터 없음
Yong Zheng
General Manager of Investment Unitno data데이터 없음데이터 없음
Jie Wang
Director of Personnelno data데이터 없음데이터 없음
Ka Man Ng
Company Secretary5.8yrs데이터 없음데이터 없음

4.5yrs

평균 재임 기간

49yo

평균 연령

경험이 풍부한 관리: 1345 의 관리팀은 경험 ( 4.5 년 평균 재직 기간)으로 간주됩니다.


이사회 구성원

이름위치테뉴어보상소유권
Zhang Xinzhou Li
Executive Chairman11.8yrsCN¥2.05m0.95%
HK$ 25.6m
Yuewen Yang
CEO & Executive Director2.3yrsCN¥655.00k데이터 없음
Quan Zhang
General Manager of Dental Business Division & Executive Director1.2yrsCN¥717.00k데이터 없음
Chanshu Lai
Independent Non-Executive Director3yrsCN¥270.00k데이터 없음
Hong Zhang
Independent Non-Executive Director5.9yrs데이터 없음데이터 없음
Mingfei Hu
Non-Executive Director4yrsCN¥184.00k데이터 없음
Changhai Zhang
Independent Non-Executive Directorless than a year데이터 없음데이터 없음

3.0yrs

평균 재임 기간

60yo

평균 연령

경험이 풍부한 이사회: 1345 의 이사회경험(평균 재직 기간 3 년)으로 간주됩니다.


기업 분석 및 재무 데이터 현황

데이터마지막 업데이트(UTC 시간)
기업 분석2024/12/22 10:42
장 마감 주가2024/12/20 00:00
수익2024/06/30
연간 수익2023/12/31

데이터 소스

기업 분석에 사용된 데이터는 S&P Global Market Intelligence LLC의 데이터입니다. 이 보고서를 생성하기 위해 분석 모델에 사용된 데이터는 다음과 같습니다. 데이터는 정규화되어 있으므로 소스가 제공되기까지 지연이 발생할 수 있습니다.

패키지데이터기간미국 소스 예시 *
회사 재무10년
  • 손익 계산서
  • 현금 흐름표
  • 대차 대조표
애널리스트 컨센서스 추정치+3년
  • 재무 예측
  • 애널리스트 목표가
시장 가격30년
  • 주식 가격
  • 배당금, 분할 및 액션
소유권10년
  • 최대 주주
  • 내부자 거래
관리10년
  • 리더십 팀
  • 이사회
주요 개발 사항10년
  • 회사 공지 사항

* 미국 증권의 경우, 미국 외 지역의 규제 양식 및 출처가 사용된 예입니다.

명시되지 않는 한 모든 재무 데이터는 1년을 기준으로 하지만 분기별로 업데이트됩니다. 이를 후행 12개월(TTM) 또는 최근 12개월(LTM) 데이터라고 합니다. 여기에서 자세히 알아보세요.

분석 모델 및 눈송이

이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 Github 페이지에서 확인할 수 있으며, 보고서 사용 방법에 대한 가이드와 튜토리얼도 유튜브에서 확인할 수 있습니다.

Simply 월스트리트 분석 모델을 설계하고 구축한 세계적인 수준의 팀에 대해 알아보세요.

산업 및 부문 메트릭

업계 및 섹션 지표는 Simply Wall St에서 6시간마다 계산되며, 자세한 내용은 확인할 수 있습니다.

애널리스트 출처

Shanghai Pioneer Holding Ltd 6 애널리스트 중 0 애널리스트가 보고서의 입력 자료로 사용된 매출 또는 수익 추정치를 제출했습니다. 애널리스트의 제출 자료는 하루 종일 업데이트됩니다.

분석가교육기관
Bo LiBOCOM International Securities Limited
Kenneth LiCinda International Research Limited
Sze Chuen TamCore Pacific -Yamaichi International (H.K.) Limited